Santen Pharmaceutical Co's total assets for Q1 2026 were ¥408.12B, a decrease of -0.28% from the previous quarter. JP:4536 total liabilities were ¥127.91B for the fiscal quarter, a 3.07% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.